Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Joana de Matos Rodrigues"'
Autor:
Anna Sandström Gerdtsson, Joana de Matos Rodrigues, Christian Winther Eskelund, Simon Husby, Kirsten Grønbæk, Riikka Räty, Arne Kolstad, Christian Geisler, Anna Porwit, Mats Jerkeman, Sara Ek
Publikováno v:
Haematologica, Vol 108, Iss 4 (2022)
The variable outcome to standard immunochemotherapy for mantle cell lymphoma (MCL) patients is a clinical challenge. Established risk factors, including high MCL International Prognostic Index (MIPI), high proliferation (Ki-67), non-classic (blastoid
Externí odkaz:
https://doaj.org/article/fd3814cc49814ec6ad284198f9418857
Autor:
Magali, Merrien, Agata M, Wasik, Elin, Ljung, Mohammad H A, Morsy, Joana, de Matos Rodrigues, Mattias, Carlsten, Georgios Z, Rassidakis, Birger, Christensson, Arne, Kolstad, Mats, Jerkeman, Sara, Ek, Nikolas, Herold, Björn E, Wahlin, Birgitta, Sander
Publikováno v:
Virchows Archiv : an international journal of pathology. 480(3)
SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase (dNTPase) that restricts viral replication in infected cells and limits the sensitivity to cytarabine by hydrolysing its active metabolite, as recently shown in acute myeloid leukemia. Cyta
Autor:
Lavanya Lokhande, Joana de Matos Rodrigues, Anna Sandstrom Gerdtsson, Anna Porwit, Mats Jerkeman, Sara Ek
Publikováno v:
Cancer Research. 82:6327-6327
Background: In precision medicine era, we need to develop tools that better predict treatment response with, for e.g. immuno-oncology drugs. One hypothesis is that diverse treatment response is governed by differences in the tumor microenvironment (T